Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Change in Receivables: 2011-2024

Historic Change in Receivables for Abeona Therapeutics (ABEO) over the last 13 years, with Dec 2024 value amounting to -$792,000.

  • Abeona Therapeutics' Change in Receivables rose 48.15% to -$14,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3,000, marking a year-over-year increase of 100.37%. This contributed to the annual value of -$792,000 for FY2024, which is 138.80% down from last year.
  • According to the latest figures from FY2024, Abeona Therapeutics' Change in Receivables is -$792,000, which was down 138.80% from $2.0 million recorded in FY2023.
  • In the past 5 years, Abeona Therapeutics' Change in Receivables registered a high of $3.0 million during FY2021, and its lowest value of -$3.0 million during FY2022.
  • Over the past 3 years, Abeona Therapeutics' median Change in Receivables value was -$792,000 (recorded in 2024), while the average stood at -$583,667.
  • Per our database at Business Quant, Abeona Therapeutics' Change in Receivables slumped by 200.00% in 2022 and then surged by 168.03% in 2023.
  • Over the past 4 years, Abeona Therapeutics' Change in Receivables (Yearly) stood at $3.0 million in 2021, then slumped by 200.00% to -$3.0 million in 2022, then skyrocketed by 168.03% to $2.0 million in 2023, then slumped by 138.80% to -$792,000 in 2024.